We are updating our Privacy Policy and Terms and Conditions to help you clearly understand how your personal information is collected, stored and managed. Learn More
Menu Back toIs-It-Time-to-Change-the-Content-and-Format-of-Labeling

DIA 2018 Global Annual Meeting

The DIA 2018 Global Annual Meeting brings together thousands of innovators from around the globe.

Is It Time to Change the Content and Format of Labeling?

    Session Chair(s)
      Ingrid Stahl Bryzinski, MS, RPh

      Ingrid Stahl Bryzinski, MS, RPh

      • Senior Director, Global Labeling
      • AbbVie, United States
    How do you make labeling useful to patients and healthcare providers (HCPs) using the latest technology? This interactive panel session will include an FDA speaker, a patient representative, and an industry speaker, who will each provide insights into ensuring product labeling is useful and informative.
    Learning Objective : Identify new requirements for labeling content and format; Discuss opportunities for future enhancements to labeling to improve utility for patients and healthcare providers.
      Eric  Brodsky, MD

      FDA Perspective

      Eric Brodsky, MD

      • Associate Director. Labeling Development Team (LDT), OND, CDER
      • FDA, United States
      Jeff  Allen, PhD

      Patient Perspective

      Jeff Allen, PhD

      • President and Chief Executive Officer
      • Friends of Cancer Research, United States
      Kathy A. Clark, BSN, RN

      Industry Perspective

      Kathy A. Clark, BSN, RN

      • Director, Global Regulatory Affairs, US Advertising and Promotion
      • Eli Lilly and Company, United States